Please login to the form below

Not currently logged in
Email:
Password:

osteoporosis

This page shows the latest osteoporosis news and features for those working in and with pharma, biotech and healthcare.

Amgen and UCB’s Evenity recommended by NICE for severe osteoporosis

Amgen and UCB’s Evenity recommended by NICE for severe osteoporosis

In the UK, almost four million people are affected by osteoporosis, resulting in around 520, 000 fragility fractures each year. ... Postmenopausal women are disproportionately impacted by the condition and have a 50% chance of experiencing an osteoporosis

Latest news

More from news
Approximately 12 fully matching, plus 193 partially matching documents found.

Latest Intelligence

  • A new era for UK-Japanese scientific research relations A new era for UK-Japanese scientific research relations

    Japan’s health system is seeing a corresponding rise in the conditions common to an ageing population, such as cardiac disease, autoimmune diseases, diabetes, osteoporosis and osteoarthritis.

  • On our best behaviour On our best behaviour

    Poor adherence for example can completely undermine the value of medication – one study showed that poor adherence with osteoporosis medications results in around a 50% reduction in the potential benefits observed

  • The evolution of marketing – the Amgen way The evolution of marketing – the Amgen way

    There is tremendous opportunity – and a massive need – to bend the curve for serious illnesses, such as cancer, cardiovascular disease and osteoporosis, which affect tens of millions of people worldwide.

  • Case study: frACTure Case study: frACTure

    The campaign featured on- and off-line communications and activities that educated employees about osteoporosis and fractures. ... It showed how committed the company is to raising awareness of osteoporosis and fragility fractures.

  • Deal Watch September 2016 Deal Watch September 2016

    Dr Reddy's has expanded its collaboration with Amgen in India adding three approved products: Xgeva for treating bone metastases, Vectibix in colorectal cancer therapy and Prolia for osteoporosis.

More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 6 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....